American Association for Cancer Research
15417786mcr200679-sup-248752_3_supp_6959787_qpd93b.pdf (504.36 kB)

Supplementary Figure S2 from EWS-FLI1 and Menin Converge to Regulate ATF4 Activity in Ewing Sarcoma

Download (504.36 kB)
journal contribution
posted on 2023-04-03, 19:42 authored by Jennifer A. Jiménez, April A. Apfelbaum, Allegra G. Hawkins, Laurie K. Svoboda, Abhijay Kumar, Ramon Ocadiz Ruiz, Alessandra X. Garcia, Elena Haarer, Zeribe C. Nwosu, Joshua Bradin, Trupta Purohit, Dong Chen, Tomasz Cierpicki, Jolanta Grembecka, Costas A. Lyssiotis, Elizabeth R. Lawlor

Supplementary Figure S2. Effect of shFLI1 knockdown in CHLA10 Ewing sarcoma cells and Publicly Available ChIP-seq of EWS-FLI1 at the ATF4 and SSP Gene Promoters.


National Institute of Health

Rogel Cancer Center



Ewing sarcomas are driven by EWS–ETS fusions, most commonly EWS-FLI1, which promotes widespread metabolic reprogramming, including activation of serine biosynthesis. We previously reported that serine biosynthesis is also activated in Ewing sarcoma by the scaffolding protein menin through as yet undefined mechanisms. Here, we investigated whether EWS-FLI1 and/or menin orchestrate serine biosynthesis via modulation of ATF4, a stress-response gene that acts as a master transcriptional regulator of serine biosynthesis in other tumors. Our results show that in Ewing sarcoma, ATF4 levels are high and that ATF4 modulates transcription of core serine synthesis pathway (SSP) genes. Inhibition of either EWS-FLI1 or menin leads to loss of ATF4, and this is associated with diminished expression of SSP transcripts and proteins. We identified and validated an EWS–FLI1 binding site at the ATF4 promoter, indicating that the fusion can directly activate ATF4 transcription. In contrast, our results suggest that menin-dependent regulation of ATF4 is mediated by transcriptional and post-transcriptional mechanisms. Importantly, our data also reveal that the downregulation of SSP genes that occurs in the context of EWS-FLI1 or menin loss is indicative of broader inhibition of ATF4-dependent transcription. Moreover, we find that menin inhibition similarly leads to loss of ATF4 and the ATF4-dependent transcriptional signature in MLL-rearranged B-cell acute lymphoblastic leukemia, extending our findings to another cancer in which menin serves an oncogenic role. These studies provide new insights into metabolic reprogramming in Ewing sarcoma and also uncover a previously undescribed role for menin in the regulation of ATF4.

Usage metrics

    Molecular Cancer Research



    Ref. manager